Psychosis News and Research RSS Feed - Psychosis News and Research

Psychosis means abnormal condition of the mind, and is a generic psychiatric term for a mental state often described as involving a "loss of contact with reality". People suffering from psychosis are said to be ''psychotic.''
Early neuropsychiatric symptoms prevalent in PD

Early neuropsychiatric symptoms prevalent in PD

Neuropsychiatric symptoms, but not cognitive impairment, are common in early untreated patients with Parkinson’s disease, suggest findings from the multicentre Parkinson’s Progression Markers Initiative. [More]
Study: Broken communication in brain regions appears to worsen Huntington's disease

Study: Broken communication in brain regions appears to worsen Huntington's disease

Indiana University researchers have found that broken communication in a specific part of the brain plays a role in the involuntary physical movements that affect individuals with Huntington's disease. [More]
Long-term effects of using cognitive-enhancing drugs by healthy people need to be determined

Long-term effects of using cognitive-enhancing drugs by healthy people need to be determined

The government, pharmaceutical industry, and national medical organisations need to work together to look at the harms and benefits of long-term use of cognitive-enhancing drugs by healthy individuals, say neuroscientists Professor Barbara Sahakian and Dr Sharon Morein-Zamir from the University of Cambridge in the UK, writing in a Personal View in The Lancet Psychiatry journal. [More]
Antibodies may trigger psychiatric illness in children

Antibodies may trigger psychiatric illness in children

A world first study revealing the presence of two antibodies in a sub-group of children experiencing their first episode of psychosis affirms a longstanding recognition that auto-immune disorders play a significant role in psychiatric illness. [More]
People with severe schizophrenia have major differences in brain networks

People with severe schizophrenia have major differences in brain networks

People with a severe form of schizophrenia have major differences in their brain networks compared to others with schizophrenia, bipolar disorder and healthy individuals, a new study from the Centre for Addiction and Mental Health shows. [More]
Tourette syndrome patients may face second psychiatric disorder during their lifetimes

Tourette syndrome patients may face second psychiatric disorder during their lifetimes

A new study of Tourette syndrome (TS) led by researchers from UC San Francisco and Massachusetts General Hospital has found that nearly 86 percent of patients who seek treatment for TS will be diagnosed with a second psychiatric disorder during their lifetimes, and that nearly 58 percent will receive two or more such diagnoses. [More]
Stepped-care strategy improves function, decreases pain severity in veterans

Stepped-care strategy improves function, decreases pain severity in veterans

Although U.S. military veterans who have returned from Iraq or Afghanistan are more likely to suffer chronic pain than veterans of any other conflict in American history, little headway has been made in helping them manage the often debilitating effects of chronic pain. [More]
Better interventions possible for children experiencing acute psychosis with antibodies

Better interventions possible for children experiencing acute psychosis with antibodies

Antibodies defend the body against bacterial, viral, and other invaders. But sometimes the body makes antibodies that attack healthy cells. In these cases, autoimmune disorders develop. [More]

Psychedelics does not increase risk of mental health problems

The use of psychedelics, such as LSD and magic mushrooms, does not increase a person's risk of developing mental health problems, according to an analysis of information from more than 135,000 randomly chosen people, including 19,000 people who had used psychedelics. [More]
Non-drug approaches work better in people with Alzheimer's disease, dementia

Non-drug approaches work better in people with Alzheimer's disease, dementia

Doctors write millions of prescriptions a year for drugs to calm the behavior of people with Alzheimer's disease and other types of dementia. But non-drug approaches actually work better, and carry far fewer risks, experts conclude in a new report. [More]
New model of care decreases likelihood of serious illness after discharge from ICU

New model of care decreases likelihood of serious illness after discharge from ICU

The Critical Care Recovery Center care model -- the nation's first collaborative care concept focusing on the extensive cognitive, physical and psychological recovery needs of intensive care unit survivors -- decreases the likelihood of serious illness after discharge from an ICU, according to a new study from the Regenstrief Institute and the Indiana University schools of medicine and nursing. [More]
Majority of Canada's homeless adults with mental illness show evidence of cognitive deficits

Majority of Canada's homeless adults with mental illness show evidence of cognitive deficits

Nearly three-quarters of homeless adults with mental illness in Canada show evidence of cognitive deficits, such as difficulties with problem solving, learning and memory, new research has found. [More]
Hallucinations linked to self-destructive thoughts among adolescents with psychological symptoms

Hallucinations linked to self-destructive thoughts among adolescents with psychological symptoms

Visual distortions and hallucinations related to an elevated risk of psychosis are linked to self-destructive thought processes among adolescents with psychological symptoms, according to a recent Finnish study. Early indications of the risk of psychosis can usually be detected long before the onset of a full-blown disorder. [More]
FDA approves RYTARY for Parkinson's disease treatment

FDA approves RYTARY for Parkinson's disease treatment

Impax Pharmaceuticals, a division of Impax Laboratories, Inc., today announced that the U.S. Food and Drug Administration approved RYTARY, an extended-release oral capsule formulation of carbidopa-levodopa, for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication and / or manganese intoxication. [More]

Longitudinal course of schizophrenia negative symptoms revealed

Schizophrenia negative symptoms are relatively stable in the first year for most patients after they begin antipsychotic medication but research suggests around a quarter will experience exacerbation or relapse. [More]
Comorbid OCD not uncommon in bipolar disorder

Comorbid OCD not uncommon in bipolar disorder

Co-occurrence of obsessive compulsive disorder in patients with bipolar disorder type I is not uncommon and is associated with increased functional disability, research findings indicate. [More]
Additional products seized from Calgary stores contain undeclared drug ingredients

Additional products seized from Calgary stores contain undeclared drug ingredients

Further to its recent Advisory, Health Canada has identified additional products seized from two Samson's Supplements stores in Calgary that pose a risk to health. [More]
Unauthorized weight loss product seized from two retail locations in southwest of Calgary

Unauthorized weight loss product seized from two retail locations in southwest of Calgary

The unauthorized product "Hydro-Lean" was seized from two Calgary stores because the label indicates it contains a combination of ingredients that can cause serious health risks (ephedrine and caffeine). [More]

Social environment not linked to UHR psychosis transition

Research indicates that social deprivation and migrant status do not influence the risk of transition to psychosis in ultra-high-risk individuals. [More]
National survey shows decrease in alcohol, cigarette and illicit drug use among U.S. teens

National survey shows decrease in alcohol, cigarette and illicit drug use among U.S. teens

A national survey of students in U.S. middle schools and high schools shows some important improvements in levels of substance use. [More]
Advertisement